Global X China Biotech Innovation ETF (CHB)
| Assets | $2.63M |
| NAV | $9.74 |
| Expense Ratio | 0.65% |
| PE Ratio | 30.84 |
| Shares Out | 270,000 |
| Dividend (ttm) | $0.02 |
| Dividend Yield | 0.21% |
| Ex-Dividend Date | Dec 29, 2022 |
| 1-Year Return | -38.24% |
| Volume | 2,223 |
| Open | 9.66 |
| Previous Close | 9.74 |
| Day's Range | 9.42 - 9.66 |
| 52-Week Low | 8.02 |
| 52-Week High | 15.64 |
| Beta | 0.12 |
| Holdings | 31 |
| Inception Date | Sep 22, 2020 |
About CHB
The Global X China Biotech Innovation ETF (CHB) is an exchange-traded fund that is based on the Solactive China Biotech Innovation index. The fund tracks a market-cap weighted index of Chinese companies that are involved in the biotechnology industry. CHB was launched on Sep 22, 2020 and is managed by Global X.
Top 10 Holdings
61.53% of assets| Name | Symbol | Weight |
|---|---|---|
| WUXI BIOLOGICS CAYMAN INC | 2269.HK | 9.61% |
| WALVAX BIOTECHNOLOGY CO-A | 300142.SZ | 7.81% |
| CSPC PHARMACEUTI | 1093.HK | 7.77% |
| CHANGCHUN HIGH-A | 000661.SZ | 7.05% |
| CHONGQING ZHIF-A | 300122.SZ | 6.95% |
| Zai Lab Limited | ZLAB | 5.35% |
| HUALAN BIOLOGI-A | 002007.SZ | 4.35% |
| SHANGHAI RAAS -A | 002252.SZ | 4.32% |
| BEIJING TIAN-A | 600161.SS | 4.27% |
| DAAN GENE CO LTD-A | 002030.SZ | 4.05% |
News
Capitalize on Biotech Growth in China With This ETF
After a rough 2021 that featured the Evergrande Crisis and heavy regulatory measures on technology to keep monopolistic moves in check, investors are eyeing opportunities in China. One of the sectors of...
Innovation Should Help Fuel Growth in This China Biotech ETF
Growth opportunities are abounding in Chinese biotech. A confluence of regulatory reforms, industry talent, and the re-opening of the country's capital markets have helped propel China's biotech industr...
5 Top-Performing ETFs of Last Week
Wall Street was downbeat last week on inflationary concerns and some downbeat economic data points.
The CHB ETF: China's Burgeoning Biotech Sector
As China continues to lead the global recovery, one area to keep a close eye on is biotechnology and the Global X China Biotech Innovation ETF (CHB). CHB seeks to provide investment results that corresp...
3 Biotech Stocks With Eye-Catching Pipelines
Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist. The post 3 Biotech Stocks With Eye-Catching Pipelines appeared first on InvestorP...
China's Quest for a Covid-19 Vaccine Could Help Boost This ETF
All around the world, economic superpowers are vying to be the first to develop a vaccine for Covid-19. China is an obvious contender given that the country was the epicenter of the virus and their succ...